BDX logo

BDX Becton, Dickinson and Company

New York Stock Exchange · Medical - Instruments & Supplies · Healthcare

$212.78
+0.10 (+0.05%)

Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, med…

Market Cap: $57.96Bwww.bd.com

Price

$176.86+18.67%
$140.71$152.83$164.95$177.07
Apr 30Aug 7

Social Signal Score

52
5d
50
3 mentions
+0.0%
30d
52
17 mentions
+0.0%
60d
54
32 mentions
+0.0%
90d
54
37 mentions
+0.0%
news: 32 · rss: 4 · marketaux: 1

Analyst Ratings

34 analysts
Buyconsensus
Strong Buy 0Buy 16Hold 16Sell 2Strong Sell 0
Avg price target$200.57-5.7%
Low $165Median $190High $242
Current Consensus

Revenue

$5.27B+80.49%
$2.92B$3.91B$4.90B$5.89B
Dec 2016Sep 2026

Analyst Estimates

FY2026
$12.67
$12.50–$12.68
8 analysts
FY2027
$13.25+5% YoY
$13.12–$13.77
8 analysts
FY2028
$14.23+7% YoY
$13.85–$14.45
8 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Thomas E. Polen Jr.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
60,000
Beta
0.28
Country
US
Piotroski score
7 / 9 (Strong)
Altman Z-score
1.86
www.bd.com